PANRAX 40 IV

PANRAX 40 IV Specification

Dosage Form
Injection

Origin of Medicine
Allopathic

Indication
Peptic ulcer, Zollinger-Ellison syndrome, GERD, Gastric hypersecretory conditions

Pacakaging (Quantity Per Box)
1 vial

Salt Composition
Pantoprazole Sodium 40 mg

Drug Type
Generic

Ingredients
Pantoprazole Sodium Sesquihydrate

Physical Form
Liquid Injection

Function
Acid reducer, Proton pump inhibitor

Recommended For
Gastric ulcer, Acid reflux, Peptic ulcer, Gastroesophageal reflux disease (GERD)

Dosage
40 mg per vial

Dosage Guidelines
As directed by the physician, to be administered intravenously

Suitable For
Adults

Storage Instructions
Store below 25C, protect from light and moisture

About PANRAX 40 IV

Unlock potent relief with PANRAX 40 IVcrafted for hospital and clinical settings. This heroic, allopathic solution harnesses Valorous Pantoprazole Sodium Sesquihydrate (40 mg) to effectively combat gastric ulcers, acid reflux, peptic ulcers, and GERD. Limited stock available at the lowest priceonly one vial per pack. For IV use only; dissolve in 10 mL sterile water. Experience powerful acid reduction within 3060 minutes. Shelf life: 24 months. Rx required. Reclaim digestive comfort with PANRAX 40 IVs distinguished and trusted formulation.

Features & Applications of PANRAX 40 IV

PANRAX 40 IV is renowned for its fast-acting acid reduction properties, suitable for hospitals and clinics in treating peptic ulcer, gastric hypersecretory conditions, and GERD. Valorous dosage and composition make it ideal for adults requiring potent medical intervention. Its application is directed by physicians, ensuring tailored and effective care. Used by healthcare professionals nationwide, PANRAX 40 IV delivers reliable results for those fighting acute digestive conditions.

FOB Port, Sample Policy, and Domestic Reach

PANRAX 40 IVs FOB Port is located across major Indian trading hubs, ready to estimate freight charges for dealer proposals. Sample policy includes trial quantities for verified healthcare entities. Proposal amount covers competitive rates with transparent shipping costs. Main domestic market spans all India, ensuring availability for exporter and distributor networks. Reliable logistics guarantee safe product arrival at your port, maintaining superior quality from storage to delivery.

FAQs of PANRAX 40 IV:

Q: How should PANRAX 40 IV be administered in clinical settings?

A: PANRAX 40 IV must be administered intravenously by dissolving the powder in 10 mL sterile water for injection, strictly under physician supervision for accurate dosing.

Q: What medical conditions is PANRAX 40 IV recommended for?

A: PANRAX 40 IV is prescribed for gastric ulcers, acid reflux, peptic ulcers, gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and other gastric hypersecretory conditions.

Q: When does PANRAX 40 IV begin to relieve symptoms after administration?

A: The onset of action for PANRAX 40 IV is typically within 30 to 60 minutes after intravenous administration.

Q: Where should PANRAX 40 IV be stored to maintain its efficacy?

A: Store PANRAX 40 IV below 25C, protecting it from light and moisture, to preserve its potency and shelf life of 24 months from the manufacturing date.

Q: What is the process for reconstituting PANRAX 40 IV before use?

A: The reconstitution process involves dissolving the contents of each vial in 10 mL of sterile water for injection prior to intravenous administration.

Q: What benefits does PANRAX 40 IV offer in hospital environments?

A: PANRAX 40 IV provides rapid and reliable acid reduction, supporting effective treatment in acute gastric conditions for adult patients, with trusted results in hospital and clinical use.